Balanced news tone
News Sentiment
ZEAL sentiment intelligence
Zealand Pharma A/S news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
82/100 classification confidence.
directly relevant articles
high-authority source matches
-6.5% over one week, -4.7% over four weeks, trend inactive, and near fair-value range.
Zealand Pharma (CPSE:ZEAL) Stock Stays Reasonable On Earnings Yet Richer On Fair Value
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Zealand Pharma (CPSE:ZEAL) Stock Stays Reasonable On Earnings Yet Richer On Fair Value
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 07 Jul 2026 07:00
- Source
- Market source
Zealand Pharma - Transactions related to share buy-back program (week 26, 2026)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 Jun 2026 15:00
- Source
- marketscreener.com
Zealand Pharma - Transactions related to share buy-back program (week 25, 2026)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 Jun 2026 07:00
- Source
- marketscreener.com
UBS Cuts Price Target on Zealand Pharma
- Tone
- Negative 34/100
- Event
- Analyst action
- Published
- 16 Jun 2026 07:00
- Source
- marketscreener.com
DNB Carnegie trims Zealand Pharma price target to DKK 425 (440), reiterates Buy
- Tone
- Positive 66/100
- Event
- Analyst action
- Published
- 10 Jun 2026 07:00
- Source
- marketscreener.com
Why The Narrative Around Zealand Pharma (CPSE:ZEAL) Is Shifting After Target Resets And Trial Updates
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 08 Jun 2026 07:00
- Source
- Market source
Deutsche Bank raises Zealand Pharma price target to DKK 300 (275), reiterates Hold
- Tone
- Positive 66/100
- Event
- Analyst action
- Published
- 03 Jun 2026 07:00
- Source
- marketscreener.com
Zealand Pharma's (CPH:ZEAL) Solid Profits Have Weak Fundamentals
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 May 2026 07:00
- Source
- simplywall.st
Analysts Have Made A Financial Statement On Zealand Pharma A/S' (CPH:ZEAL) First-Quarter Report
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 11 May 2026 07:00
- Source
- simplywall.st
Zealand Pharma initiates USD 200 million / DKK 1.3 billion share buy-back program
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 07 May 2026 07:00
- Source
- marketscreener.com
Assessing Zealand Pharma (CPSE:ZEAL) Valuation As New Cambridge Research Hub Expands AI Drug Discovery
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 25 Mar 2026 07:00
- Source
- Market source
Zealand Pharma (CPSE:ZEAL) Is Up 14.2% After Obesity Drug Petrelintide Hits Phase 2 Goal - Has The Bull Case Changed?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Mar 2026 07:00
- Source
- simplywall.st
Zealand Pharma (ZEAL) Stock Drops 32% After Obesity Drug Trial Misses Targets
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 06 Mar 2026 08:00
- Source
- CoinCentral
Zealand Pharma A/S (CPH:ZEAL) most popular amongst retail investors who own 46% of the shares, institutions hold 38%
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Feb 2026 08:00
- Source
- simplywall.st
Zealand Pharma Slips as KBC Securities Cuts Its Price Target
- Tone
- Negative 34/100
- Event
- Analyst action
- Published
- 05 Feb 2026 08:00
- Source
- marketscreener.com
Is Weakness In Zealand Pharma A/S (CPH:ZEAL) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 25 Jan 2026 08:00
- Source
- simplywall.st
Assessing Zealand Pharma (CPSE:ZEAL) Valuation After Prolonged Share Price Weakness
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 24 Jan 2026 08:00
- Source
- Market source
Zealand Pharma A/S: Target Price Consensus and Analysts Recommendations | ZEAL | DK0060257814
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 18 Aug 2020 23:42
- Source
- marketscreener.com
Zealand Pharma A/S Announces Board Changes
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 Apr 2020 07:00
- Source
- marketscreener.com